SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
-22.13%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$395M
AUM Growth
+$395M
(-21%)
Cap. Flow
+$43.8M
Cap. Flow
% of AUM
11.07%
Top 10 Holdings %
Top 10 Hldgs %
64.49%
Holding
56
New
7
Increased
4
Reduced
3
Closed
–
Top Buys
1 |
Arcellx
ACLX
|
$14M |
2 |
Zymeworks
ZYME
|
$6.36M |
3 |
ALX Oncology
ALXO
|
$4.44M |
4 |
Scholar Rock
SRRK
|
$4.38M |
5 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$4.37M |
Top Sells
1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$4.57M |
2 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$345K |
3 |
Nkarta
NKTX
|
$11 |
Sector Composition
1 | Healthcare | 97.99% |
2 | Financials | 2.01% |